{
    "nctId": "NCT02167659",
    "briefTitle": "Bioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema (PREVENT)",
    "officialTitle": "A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement in the Prevention of Lymphedema Following Locoregional Treatment for Breast Cancer (PREVENT)",
    "overallStatus": "COMPLETED",
    "conditions": "Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 1201,
    "primaryOutcomeMeasure": "Rate of progression of lymphedema",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed invasive breast cancer or Ductal Carcinoma In Situ (DCIS)\n* Planned surgical procedure\n* Ability to understand and the willingness to sign a written informed consent document.\n\nExclusion Criteria:\n\n* Prior history of breast cancer, breast/chest wall/axillary radiation therapy\n* Definitive breast surgical procedure prior to enrollment.\n* Active implanted medical device (e.g., cardiac pacemakers, defibrillators) or patients connected to electronic life support devices or metallic devices that would interfere with BIS measurements.\n* Conditions that could cause swelling (e.g., pregnancy, congestive heart failure, chronic/acute renal disease, cor pulmonale, nephrotic syndrome, nephrosis, liver failure or cirrhosis, pulmonary edema, and thrombophlebitis, or deep vein thrombosis in arms\n* Previous treatment for lymphedema of either arm.\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, unstable angina pectoris, or cardiac arrhythmia.\n* Psychiatric illness (e.g., diagnosed schizophrenia or documented dementia) that would limit compliance with study requirements.\n* Known allergy to electrode adhesives or woven knit compression fabrics\n* Bilateral breast cancer or planned bilateral mastectomy",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}